Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Cash from Operations (2020 - 2025)

Celularity (CELU) has disclosed Cash from Operations for 6 consecutive years, with 4159000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Operations fell 2788.19% to 4159000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 6557000.0, a 46.85% increase, with the full-year FY2024 number at 6401000.0, up 83.45% from a year prior.
  • Cash from Operations was 4159000.0 for Q3 2025 at Celularity, down from 999000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1594000.0 in Q4 2024 to a low of 37720000.0 in Q3 2022.
  • A 5-year average of 15853105.26 and a median of 11027000.0 in 2023 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: plummeted 8009.32% in 2021, then surged 136.72% in 2024.
  • Celularity's Cash from Operations stood at 32045000.0 in 2021, then rose by 7.68% to 29585000.0 in 2022, then surged by 85.33% to 4341000.0 in 2023, then soared by 136.72% to 1594000.0 in 2024, then tumbled by 360.92% to 4159000.0 in 2025.
  • Per Business Quant, the three most recent readings for CELU's Cash from Operations are 4159000.0 (Q3 2025), 999000.0 (Q2 2025), and 2993000.0 (Q1 2025).